![]() BIoEclipse Therapeutics BIoEclipse Therapeutics is a biopharmaceutical company developing curative immuno-oncology therapeutics. | ![]() Coherus Oncology Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments. | ![]() Neovii Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
| ImmPACT-Bio ImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy. | |
Founding Date | Founding Date N/A | Founding Date 2010 | Founding Date 2003 | Founding Date 2017 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations South San Francisco, US HQ Mountain View, US | Locations Redwood City, US HQ Camarillo, US | Locations Rapperswil-Jona, CH HQ Gräfelfing, DE Lexington, US | Locations Camarillo, US HQ Rishon Le Tsiyon, IL |
Employees | Employees 614% decrease | Employees 14736% decrease | Employees 1193% increase | Employees 845% decrease |
Funding | ||||
Latest funding round | Latest funding round $ 7.7m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 18m (almost 6 years ago) |
Total funding raised | Total funding raised $ 7.7m | Total funding raised $ 174.5m | Total funding raised N/A | Total funding raised $ 18m |

Coherus BioSciences is a biopharmaceutical company that focuses on the research, development, and commercialization of cancer treatments.
View company
Neovii is a company specializing in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology and oncology.
View companyImmPACT-Bio is a company that develops a chimeric antigen receptor T-cell (CAR-T) therapy.
View company